ℹ️ Compiled from public regulatory records · Last regulator revision: April 2, 2026🚩 Report this page
Efinaconazole
Imidazole and Triazole Derivatives
Sold as JUBLIA
CA Health Canada
- Drug class
- Imidazole and Triazole Derivatives
- Availability
- See label
- Routes
- Topical
- Markets covered
- 1
- Products on record
- 1
Overview
Efinaconazole is an active pharmaceutical ingredient in the Imidazole and Triazole Derivatives group (D01AC). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 1 | April 2, 2026 |
CACanada· Health Canada
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
Brands in Canada (1)
Sources & citations
- [1]Health Canada (DPD) · 02413388 · revised April 2, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.